04:27 PM EDT, 05/20/2024 (MT Newswires) -- Dyne Therapeutics ( DYN ) said Monday it has launched a proposed underwritten public offering of $300 million of its common shares.

The company also said it intends to grant underwriters a 30-day option to buy up to an additional $45 million of shares.

All of the shares are to be sold by Dyne and the offering is still subject to market and other conditions, it said.

has commenced an underwritten public offering of $300,000,000 of shares of its common stock. Dyne also intends to grant the underwriters a 30-day option to purchase up to an additional $45,000,000 of shares of its common stock. All of the shares in the proposed offering are to be sold by Dyne.

Price: 35.60, Change: +0.22, Percent Change: +0.62